Cann Global Limited
ASX Code
CGB
Sector
Pharmaceuticals- Biotechnology & Life Sciences
Investor Centre
https://www.canngloballimited.com/investor-centre/
Website
https://www.canngloballimited.com/
About
Cann Global Limited (The Company) is an Australian public company listed on the Official List of the Australian Stock Exchange (ASX: CGB). The Company was admitted to the official list of ASX on 14 January 2008. (Previous ASX code: QBL) The Group’s primary focus is to legally grow and cultivate hemp to research and develop medicinal cannabis products to service an increasing demand in the Australian and global markets. Cann Global Ltd has a 100% shareholding in Medical Cannabis Ltd (MCL) and a management agreement with Medcan Australia Pty Ltd (Medcan) which operate a business cultivating, researching, developing and soon to be distributing medicinal cannabis products in Australia. Our Medical Cannabis division has been a key value driver for the Group. The Group also retains an interest in its existing Bauxite Projects.